论文部分内容阅读
目的:探讨曼月乐治疗子宫肌瘤合并月经过多的临床效果。方法:选取2008年10月至2010年11月于本院进行治疗的45例子宫肌瘤合并月经过多患者为研究对象,于月经期第4～7天在子宫腔内放置曼月乐,随访12个月,将患者治疗前后的子宫及肌瘤体积、子宫内膜厚度、血红蛋白量、月经量进行统计及比较。结果:使用曼月乐后,患者月经量较治疗前显著减少(P<0.05);子宫内膜厚度显著变薄,血红蛋白水平也出现显著回升(P<0.05);子宫和肌瘤体积较放置前缩小,但差异没有统计学意义(P>0.05)。结论:曼月乐可以显著减少月经量,改善贫血,但不能显著缩小子宫肌瘤的体积。
Objective: To investigate the clinical effect of Mirena Levomyoma combined with menorrhagia. METHODS: Forty-five patients with uterine fibroids combined with menorrhagia who were treated in our hospital from October 2008 to November 2010 were selected as the study subjects. Mirena was placed in the uterine cavity on the 4th to 7th day of menstruation and followed up 12 months, before and after treatment of patients with uterine and fibroid volume, endometrial thickness, hemoglobin, menstrual flow statistics and comparison. Results: After using Mirena, the amount of menstruation was significantly decreased (P <0.05), the thickness of endometrium was thinner and the level of hemoglobin was significantly increased (P <0.05). The volume of uterus and fibroids was significantly lower than that before treatment Reduced, but the difference was not statistically significant (P> 0.05). Conclusion: Mirena can significantly reduce menstrual flow, improve anemia, but can not significantly reduce the size of uterine fibroids.